IPP Bureau
Croda secures financial support from UK Government for expansion of lipid systems manufacturing facility
By IPP Bureau - April 04, 2022
The investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines
Bayer to invest €1.3 billion for driving innovations in life sciences, agriculture segment
By IPP Bureau - April 03, 2022
Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
WHO suspends supply of Covaxin under Covax facility
By IPP Bureau - April 03, 2022
WHO’s post EUA inspection found deficiencies in Good Manufacturing Practice at the facility
JBCPL buys Azmarda trademark for India at Rs 246 crore
By IPP Bureau - April 03, 2022
The brand Azmarda fits well with JBCPL's overall strategy of strengthening its presence in the cardiology segment in India.
Blue Star opens medical diagnostic equipment refurbishment facility in Maharashtra
By IPP Bureau - April 03, 2022
Through this new set-up, the company intends to make available, affordable high-quality medical diagnostic imaging equipment across Tier 2, 3, and 4 towns in India
Panacea Biotec appoints NK Juneja as additional director
By IPP Bureau - April 03, 2022
He has done his Masters in Pharmacy (M. Pharm) and Post Graduate Diploma in Personnel Management & Industrial Relations
Jubilant Pharmova to acquire stake in Greencure
By IPP Bureau - April 03, 2022
There is also a strong synergy between Jubilant and Greencure with respect to OTC portfolio which can be explored for R&D, online acceleration and offline distribution
Jenburkt Wellness launches D2C brand Zixa strong
By IPP Bureau - April 03, 2022
The organization has introduced an advanced FlashMicelle technology which is a combination of ultra-rapid mixing techniques, and a uniquely powerful approach to modify the structure of oil-based formulations to improve their therapeutic efficacy substantially
Doctors at Yashoda Hospitals perform Cone Beam CT guided lung biopsy
By IPP Bureau - April 03, 2022
This state-of-art technology will help pulmonologists to diagnose lung cancer in the very early stages helping the patient get an early surgical resection
USFDA approves Yescarta as first CAR T-cell therapy for Lymphoma
By IPP Bureau - April 03, 2022
Yescarta is First CAR T-cell therapy to receive NCCN treatment guideline category 1 recommendation --
Dr. Reddy's and MediCane Health launch medical cannabis in Germany
By IPP Bureau - April 03, 2022
The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021
WHO selects Biological E for mRNA tech transfer
By IPP Bureau - April 03, 2022
Primarily set up to address the Covid-19 emergency, the WHO technology transfer hub has the potential to expand manufacturing capacity for other products as well, including treatments, and target other priorities such as malaria, HIV and cancer
New data indicate molnupiravir eliminates Covid-19 rapidly
By IPP Bureau - April 03, 2022
Among patients with infectious virus at baseline, no patients who received Lagevrio had infectious virus at days 3, 5 or 10
Lonza Joins International Pharmaceutical Aerosol Consortium
By IPP Bureau - April 01, 2022
Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
Bayer to set up 27 telemedicine centres across eight states
By IPP Bureau - April 01, 2022
Bayer will be setting up 27 telemedicine centres in 12 districts across 8 states with implementing partners Telerad RxDx and Piramal Swasthya
